摘要 |
#CMT# #/CMT# Transglutaminase 3 (I) or a fragment of (I) or a nucleic acid encoding (I) or a modulator of the activity or expression of (I) is used cosmetically to prevent or treat signs of skin aging or to prepare a therapeutic composition for this purpose. #CMT# : #/CMT# The polypeptide (I) encoded by SEQ ID NO:1 (defined sequence of 2391 nucleotides given in the specification) or a fragment of (I) or a nucleic acid encoding (I) or a modulator of the activity or expression of (I) is used cosmetically to prevent or treat signs of skin aging or to prepare a therapeutic composition for this purpose. Independent claims are also included for: (1) use of (I) to screen for compounds capable of modulating the expression or activity of (I); (2) characterizing the condition of epithelial tissue by determining the amount of (I) or (I)-encoding nucleic acid in a tissue sample and comparing the result with a reference value; (3) screening for antiaging compounds by contacting a (I)-expressing cell with a test compound and determining the amount of (I) expressed; (4) characterizing the efficacy of a cosmetic or therapeutic treatment intended to compensate for signs of skin aging by qualitatively or quantitatively characterizing the expression or biological activity of (I); (5) use of (I) or a modulator of the expression of (I) to prepare or improve a multilayer cellular model, especially a reconstructed skin model. #CMT#USE : #/CMT# Preventing or treating signs of skin aging. #CMT#BIOTECHNOLOGY : #/CMT# Preferred Materials: (I) has SEQ ID NO:2 (defined sequence of 693 amino acids given in the specification). The fragments have SEQ ID NO:3 to SEQ ID NO:32 (defined sequences of 9-18 amino acids given in the specification), e.g. Ala Ile Ile Leu Asp Asn Pro Thr Leu Glu Val. The modulator is a substance that activates expression of (I), especially an intracellular calcium mobilizer or transcription factor Sp1 or Ets, or an enzymatic activator of (I), especially cathepsin D, thapsigargin, sphingosine-phosphorylcholine, CLSP (not defined) or a guanosine triphosphate analog. #CMT#EXAMPLE : #/CMT# Analysis of skin stripping samples from menopausal women with dry skin (group AS) and young women with normal skin (group JN) showed that the ratio of transglutaminase 3 expression level in group AS to that in group JN was 532:1266. |